Peritoneal dialysis in children: Pathophysiological approaches, prescription and management of complications for adequate treatment.
DOI:
https://doi.org/10.25796/bdd.v8i2.87081Keywords:
peritoneal dialysis, pediatrics, dialysis prescription, advantages and disadvantages, renal failureAbstract
Peritoneal dialysis (PD) is the most commonly used renal replacement therapy in children worldwide. It utilizes the peritoneal membrane as a semi-permeable surface for the exchange of solutes and water between the dialysate and peritoneal capillaries. There are two main modalities: continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD), the latter being performed at home using a cycler.
Pediatric prescriptions must be individualized based on body surface area, intraperitoneal pressure (IPP), and specific dialysis needsPD is generally well tolerated and offers several advantages, such as better preservation of residual diuresis, the possibility of home-based treatment, and the continuity of schooling. It also doesn’t require anticoagulation. However, it may lead to mechanical complications (hernias, leaks, pain) and infectious ones (peritonitis, catheter-related infections),some times more frequent than in adults.
Placement of an appropriate catheter (e.g., Tenckhoff) under sterile conditions with antibiotic prophylaxis is crucial for effective and safe treatment. The adequation of dialysis take into acount the choice of dialysis solution (glucose, icodextrin, bicarbonate or lactate buffer) and prescription parameters (volume, dwell time, number of cycles) should aim to optimize clearance while preserving peritoneal membrane function, but also maintain normal child weight and height growth. PD is the technique of choice in pediatrics, PD remains a flexible, effective, and suitable alternative, especially for young children or when access to hemodialysis is limited.
INTRODUCTION
Peritoneal dialysis (PD) is the most widely used extra-renal replacement therapy in children worldwide, particularly in younger children and in low- and middle-income countries[1].
In Europe, PD is the initial treatment modality for stage 5 Chronic Kidney Disease (CKD) in 40% of cases, according to the ESPN/ERA-EDTA registry. The principle of PD lies in the use of the peritoneal membrane as a filter membrane[2].
THE PERITONEUM
The peritoneum is a membrane made up of two layers: the parietal layer and the visceral layer, which are joined by the mesos. The peritoneal membrane is made up of mesothelium, interstitium, and capillaries (Figure 1).
The peritoneal cavity is the space between the two sheets. Under physiological conditions, this “virtual” space contains less than 100 mL of a liquid formed from plasma ultrafiltrate. This effluent contains few cells (fewer than 50 cells/mL) and no neutrophils in the absence of infection[3]. This is a “functional” anatomical contact and exchange surface measuring 0.5 to 2 m2[4]. In children, the prescription of peritoneal dialysis must be individually adapted, taking into account the body surface area (expressed in mL/m²) to determine the intraperitoneal filling volume (IPF). In fact, anatomical peritoneal surface area is age-invariant if expressed per unit of body surface area [5,6].
PD exchange principle
During PD in both adults and children, the capillaries of the peritoneal surface are recruited (only 20% are perfused at rest). The abdominal pressure resulting from dialysate infusion is known as intraperitoneal pressure (IPP). Transperitoneal exchanges take place via several mechanisms, with the peritoneal membrane behaving like a semi-permeable membrane; it allows diffusion, absorption, and convection.
A mathematical model with three pore types, proposed by B. Rippe, models the transports established during PD[7]. The histological equivalent of small and large pores has not been established. This model is illustrated inFigure 1.
Figure 1.Illustration schematizing the exchange model across the various pores of the peritoneal membrane according to Rippe B.
Ultra-small pores (transcellular transport via type 1 aquaporins) are mainly responsible for osmotic gradient-mediated free water transport (usually glucose), playing a vital role at the start of the cycle, when the crystalloid gradient is strong. They are responsible for 40–50% of ultrafiltration (UF). Small pores transfer water by diffusion and convection (50–60% of overall UF), as well as water coupled with solutes (urea, creatinine, sodium, etc.). Large pores allow macromolecules to pass through.
H2O: water, R: radius, nm: nanometer
INDICATIONS AND CONTRAINDICATIONS FOR PD IN CHILDREN
It is recommended to start a replacement technique in children with an estimated glomerular filtration rate (eGFR) of less than 10 mL/min/1.73 m2, or when the child presents uremic symptoms refractory to medical treatment[2]. PD is then the technique of choice, particularly in infants, due to the absence of appropriate extra body circuits dedicated to them in chronic hemodialysis[8]. PD can be used from birth, including in premature infants[9].
However, no study has shown that one dialysis modality is superior to another in terms of survival[10]. Thus, the choice of dialysis modality depends on the convictions and possibilities of the teams in charge of the child and the choice of the family.
Advantages of PD
This is a gentle, physiological dialysis method that ensures good hemodynamic tolerance and preserves residual diuresis. Unlike hemodialysis, it does not require anticoagulation. PD also helps to maintain vascular capital, an essential factor in these young patients, who are likely to undergo several renal replacement therapies over the course of their lives. PD is carried out at home, which limits “hospital constraints.” This technique is also preferable when the family is far from the dialysis center. Nocturnal PD enables schooling to be maintained. Compared with non-intensive hemodialysis techniques, daily PD also reduces water restriction and dietary constraints. In order to optimize staturo-weight growth in children with chronic renal failure, enteral nutritional support is often necessary to cover the caloric needs required according to the child’s age[11]. In addition, children with chronic renal failure are treated with daily injections of growth hormone to optimize statural growth[12].
Disadvantages of PD
The technique can nevertheless represent a significant burden for the family, leading to difficulties with adherence in adolescents who may find the dialysis time too long. Studies on the quality of life of families of children undergoing peritoneal dialysis highlight a significant impact on their well-being[13], with a high prevalence of anxiety-depressive disorders among parents[14]. Chronic PD also leads to alterations in the peritoneal membrane. Chronic PD induces submesothelial fibrosis and neoangiogenesis, clinically reflected in altered membrane transport[15].
PD is contraindicated in children with pathologies that affect the integrity of the peritoneal membrane or cavity, such as omphalocele, bladder exstrophy, diaphragmatic hernia, laparoschisis, or obliterated peritoneal cavity. The presence of ileostomies and colostomies, significant organomegaly, living situations unsuitable for home dialysis, lack of appropriate caregiver support, and recent abdominal surgery may lead to discussion of the first-line indication for PD[16].
PRESCRIBING PD IN PRACTICE
There are several stages in the process once the indication for PD has been established, the family’s commitment to the project has been ascertained, and the feasibility of the procedure has been verified.
The practitioner will first select the catheter and ensure that it is in place and functioning properly. The PD modality
References
1. Bonthuis M, Vidal E, Bjerre A, Aydoğ Ö, Baiko S, Garneata L, et al. Ten-year trends in epidemiology and outcomes of pediatric kidney replacement therapy in Europe: data from the ESPN/ERA-EDTA Registry. Pediatr Nephrol Berl Ger. 2021 Aug;36(8):2337–48. DOI: https://doi.org/10.1007/s00467-021-04928-w
2. Warady BA, Schaefer F, Bagga A, Cano F, McCulloch M, Yap HK, et al. Prescribing peritoneal dialysis for high-quality care in children. Perit Dial Int J Int Soc Perit Dial. 2020 May;40(3):333–40. DOI: https://doi.org/10.1177/0896860819893805
3. Vrtovsnik F. Le péritoine : une membrane filtrante. Bull Académie Natl Médecine [Internet]. 2022 Feb 1 [cited 2025 May 5];206(2):187–94. Available from: https://www.sciencedirect.com/science/article/pii/S0001407921004325 DOI: https://doi.org/10.1016/j.banm.2021.10.008
4. Chagnac A, Herskovitz P, Weinstein T, Elyashiv S, Hirsh J, Hammel I, et al. The peritoneal membrane in peritoneal dialysis patients: estimation of its functional surface area by applying stereologic methods to computerized tomography scans. J Am Soc Nephrol JASN. 1999 Feb;10(2):342–6. DOI: https://doi.org/10.1681/ASN.V102342
5. Fischbach M, Dheu C, Helms P, Terzic J, Michallat AC, Laugel V, et al. The Influence of Peritoneal Surface Area on Dialysis Adequacy. Perit Dial Int [Internet]. 2005 Feb 1 [cited 2025 May 5];25(3_suppl):137–40. Available from: https://doi.org/10.1177/089686080502503S36 DOI: https://doi.org/10.1177/089686080502503S36
6. Fischbach M, Warady BA. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol Berl Ger. 2009 Sep;24(9):1633–42; quiz 1640, 1642. DOI: https://doi.org/10.1007/s00467-008-0979-7
7. Rippe B, Stelin G. How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth. Adv Perit Dial Conf Perit Dial. 1990;6:13–8.
8. Ranchin B, Schmitt CP, Warady B, Craig JC, Licht C, Hataya H, et al. Devices for long-term hemodialysis in small children-a plea for action. Kidney Int. 2023 Jun;103(6):1038–40. DOI: https://doi.org/10.1016/j.kint.2023.03.018
9. Burgmaier K, Hackl A, Ehren R, Kribs A, Burgmaier M, Weber LT, et al. Peritoneal dialysis in extremely and very low-birth-weight infants. Perit Dial Int J Int Soc Perit Dial. 2020 Mar;40(2):233–6. DOI: https://doi.org/10.1177/0896860819887292
10. Huang CC, Cheng KF, Wu HDI. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int J Int Soc Perit Dial. 2008 Jun;28 Suppl 3:S15-20. DOI: https://doi.org/10.1177/089686080802803s04
11. Shaw V, Polderman N, Renken-Terhaerdt J, Paglialonga F, Oosterveld M, Tuokkola J, et al. Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol Berl Ger. 2020 Mar;35(3):519–31. DOI: https://doi.org/10.1007/s00467-019-04426-0
12. Bechara R, Rossignol S, Zaloszyc A. [Chronic kidney disease and growth failure: Efficacy of growth hormone treatment]. Med Sci MS. 2023 Mar;39(3):271–80. DOI: https://doi.org/10.1051/medsci/2023034
13. Hajj E, Awouters M, Mosca M, Flammier S, Rachedi S, Bacchetta J, et al. Health-related quality of life in paediatric patients on peritoneal dialysis: Data from a tertiary centre. Perit Dial Int J Int Soc Perit Dial. 2025 Mar;45(2):121–3. DOI: https://doi.org/10.1177/08968608241241177
14. Lima AGT, Sales CC da S, Serafim WF de L. Burden, depression and anxiety in primary caregivers of children and adolescents in renal replacement therapy. J Bras Nefrol. 2019;41(3):356–63. DOI: https://doi.org/10.1590/2175-8239-jbn-2018-0039
15. Goffin E. Peritoneal membrane structural and functional changes during peritoneal dialysis. Semin Dial. 2008;21(3):258–65. DOI: https://doi.org/10.1111/j.1525-139X.2008.00425.x
16. Wisanuyotin S, Dell KM, Vogt BA, O’Riordan MA, Avner ED, Davis ID. Complications of peritoneal dialysis in children with Eagle-Barrett syndrome. Pediatr Nephrol Berl Ger. 2003 Feb;18(2):159–63. DOI: https://doi.org/10.1007/s00467-002-1034-8
17. Briggs VR, Jacques RM, Fotheringham J, Maheswaran R, Campbell M, Wilkie ME. Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients. Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD012478. DOI: https://doi.org/10.1002/14651858.CD012478.pub2
18. Warady BA, Same R, Borzych-Duzalka D, Neu AM, El Mikati I, Mustafa RA, et al. Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update. Perit Dial Int J Int Soc Perit Dial. 2024 Sep;44(5):303–64. DOI: https://doi.org/10.1177/08968608241274096
19. Sethna CB, Bryant K, Munshi R, Warady BA, Richardson T, Lawlor J, et al. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative. Clin J Am Soc Nephrol CJASN. 2016 Sep 7;11(9):1590–6. DOI: https://doi.org/10.2215/CJN.02540316
20. Katyal A, Mahale A, Khanna R. Antibiotic prophylaxis before peritoneal dialysis catheter insertion. Adv Perit Dial Conf Perit Dial. 2002;18:112–5.
21. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int J Int Soc Perit Dial. 2000;20(4):396–411. DOI: https://doi.org/10.1177/089686080002000406
22. Schaefer F, Klaus G, Müller-Wiefel DE, Mehls O. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol JASN. 1999 Jan;10(1):136–45. DOI: https://doi.org/10.1681/ASN.V101136
23 Fischbach, M., Issad, B., Dubois, V., & Taamma, R. (2011). The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 31(4), 450–458. https://doi.org/10.3747/pdi.2010.00146 DOI: https://doi.org/10.3747/pdi.2010.00146
24. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. «Peritoneal Equilibration Test.» Peritoneal Dialysis Bulletin. 1987;7(3):138–147. DOI: https://doi.org/10.1177/089686088700700306
25. Verger C. How to use the peritoneum as a dialysis membrane. Methods of surveillance, criteria of efficacy and longevity as a dialysis membrane, consequences with respect to techniques of peritoneal dialysis. Nephrologie. 1995;16(1):19–31.
26. Fischbach M. Peritoneal dialysis in children. Arch Pediatr Organe Off Soc Francaise Pediatr. 1997 Jan;4(1):81–9.
27. Radtke J, Lemke A, Kemper MJ, Nashan B, Koch M. Surgical complications after peritoneal dialysis catheter implantation depend on children’s weight. J Pediatr Surg [Internet]. 2016 Aug [cited 2025 May 23];51(8):1317–20. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022346815008234 DOI: https://doi.org/10.1016/j.jpedsurg.2015.12.005
28. Laakkonen H, Hölttä T, Lönnqvist T, Holmberg C, Rönnholm K. Peritoneal dialysis in children under two years of age. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2008 May;23(5):1747–53.
29. Tse KC, Yip PS, Lam MF, Li FK, Choy BY, Chan TM, et al. Recurrent hemoperitoneum complicating continuous ambulatory peritoneal dialysis. Perit Dial Int J Int Soc Perit Dial. 2002;22(4):488–91. DOI: https://doi.org/10.1177/089686080202200407
30. García Ramón R, Carrasco AM. Hydrothorax in peritoneal dialysis. Perit Dial Int J Int Soc Perit Dial. 1998;18(1):5–10. DOI: https://doi.org/10.1177/089686089801800101
31. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int. 1998 Apr;53(4):1061–7. DOI: https://doi.org/10.1046/j.1523-1755.1998.00849.x
32. Blake PG, Sloand JA, McMurray S, Jain AK, Matthews S. A multicenter survey of why and how tidal peritoneal dialysis (TPD) is being used. Perit Dial Int J Int Soc Perit Dial. 2014 Jun;34(4):458–60. DOI: https://doi.org/10.3747/pdi.2013.00314
33. Zaritsky JJ, Hanevold C, Quigley R, Richardson T, Wong C, Ehrlich J, et al. Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative. Pediatr Nephrol Berl Ger. 2018 Apr;33(4):713–22. DOI: https://doi.org/10.1007/s00467-017-3839-5
34. Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, et al. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int J Int Soc Perit Dial. 2012 Jun;32 Suppl 2(Suppl 2):S32-86. DOI: https://doi.org/10.3747/pdi.2011.00091
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 ROUBA BECHARA, Bruno Ranchin, Ariane Zaloszyc

This work is licensed under a Creative Commons Attribution 4.0 International License.






